There may be a relationship between traumatic life event stress and atrial fibrillation in women over the age of 45 years old.
Investigators observed a significant association between atrial fibrillation and increasing oxygen desaturation index.
Atrial fibrillation is associated with a faster global cognitive decline and an increased risk for dementia in older people, though anticoagulants may reduce dementia risk in AF patients.
Probands of African or Hispanic/Latino descent with early-onset atrial fibrillation are more likely than European Americans to have a first-degree relative with AF
Variations in published stroke rates for patients with AF not receiving anticoagulants result in differences in the calculated net clinical benefit of anticoagulation.
There is variation in the net clinical benefit of anticoagulants based on variation in published atrial fibrillation stroke rates.
For high-risk patients with implantable cardioverter-defibrillators, ranolazine does not significantly reduce the risk of ventricular tachycardia, or ventricular fibrillation.
The irregular rhythm notification feature analyzes pulse rate data to identify episodes of irregular heart rhythms.
The new analysis included 19,134 of these patients and showed that there were 19% fewer deaths in patients initiated on NOACs compared to VKAs at the time of AF diagnosis.
Patients with atrial fibrillation who have ≥1 non-sex CHA2DS2VASc stroke risk factor should receive oral anticoagulation as antithrombotic therapy.
Clinical outcomes in atrial fibrillation vs atrial flutter differ in terms of ischemic stroke, heart failure hospitalizations, and all-cause mortality.
Active EKG monitoring screening leads to earlier diagnosis and treatment for atrial fibrillation compared with delayed monitoringAugust 15, 2018
In this randomized controlled trial, patients who received immediate atrial fibrillation monitoring with a new, wearable EKG were more likely to have their AF diagnosed compared with the delayed monitoring group. Patients in the active monitoring group also had a higher rate of initiation of anticoagulation therapy.
Physicians responded to the USPSTF's recommendation citing insufficient evidence to assess the benefits and harms of atrial fibrillation screening in asymptomatic, older adults.
US Preventive Services Task Force says benefit of screening for atrial fibrillation is unclear in asymptomatic, older patients.
Patients with atrial fibrillation who take NSAIDs in addition to oral anticoagulants may have an increased risk for major bleeding and stroke.
Patients with higher levels of thyroid-stimulating hormone were more likely to experience atrial tachyarrhythmia after catheter ablation for atrial fibrillation.
Individuals with more frequent nighttime awakening exhibited a higher risk for atrial fibrillation.
Individuals with clinician-diagnosed asthma were at an estimated 38% higher risk for atrial fibrillation.
Apixaban demonstrated superiority over warfarin in terms of reducing the risk for major bleeding in patients with atrial fibrillation and end-stage kidney disease who were on dialysis.
Using a continuous ECG monitoring patch at home in patients at high risk for atrial fibrillation resulted in higher diagnosis rates, more anticoagulation initiation, and increased healthcare resource utilization.
Apixaban reduced risks of major, intracranial, and gastrointestinal bleeding compared with warfarin.
Increased weight loss with risk factor management associated with greater atrial fibrillation freedom.
Most common trial end point is atrial fibrillation or atrial flutter recurrence; rates of primary clinical end points are low.
Higher risk for atrial fibrillation seen across multiple cohorts, regardless of obstructive sleep apnea and other possible factors.
Troponin-T, N-terminal pro-B-type natriuretic peptide, and growth differentiation factor-15 may offer prognostic utility on mortality and bleeding events in patients with atrial fibrillation who receive anticoagulation.
Data from large Phase 3 studies showed that treatment with rivaroxaban was found to be safe and effective in older patients.
Job strain linked with increased risk for incident atrial fibrillation.
The system is intended for properly selected trained users ≥22 years of age who have been stabilized on anticoagulation with vitamin K antagonists for ≥6 weeks.
A greater burden of atrial fibrillation or flutter in patients with paroxysmal atrial fibrillation was associated with a higher risk for stroke when not taking anticoagulants.
Patients with COPD had a nearly 2-fold increased risk for developing atrial fibrillation compared with patients without COPD.
The Cardiology Advisor Articles
- Class 1 Device Recall: Endologix AFX Device Recalled Due to Type III Endoleaks
- Harvard: Fraudulent Data Found in Publications of Heart Researcher
- Traumatic Life Events May Increase Risk for Atrial Fibrillation in Older Women
- No Differences Between Bivalirudin, UFH Post-PCI After Ticagrelor Pretreatment
- Rivaroxaban Approved to Reduce Risk of Major Cardiovascular Events in CAD, PAD
- Coenzyme Q10 Supplementation May Reduce Statin-Induced Myopathy
- Long-Term Exposure to Elevated BP Associated With AS and AR
- Risk Factors for Atherosclerotic Cardiovascular Disease in the South Asian Population
- Takotsubo Syndrome Associated With Substantial Morbidity, Mortality
- Bariatric Surgery Reduces Macrovascular Complications in Obesity, T2D
- Metformin May Improve Vascular Health in Adolescents With Type 1 Diabetes
- Improved Cardiovascular Event Reporting Needed in Leukemia Clinical Trials
- Psoriasis Associated With Clinical Signs of Accelerated Atherosclerosis
- Can Dermatoscope Magnets Be Used With CV Implanted Electronic Devices?
- The Striking Effects of Diversity in Health Care: Improving Patient Outcomes